 NEW YORK, June 2, 2021 PRNewswire -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Constellation Pharmaceuticals, Inc. Constellation or the Company NASDAQ: CNST in connection with the proposed acquisition of the Company by MorphoSys AG MorphoSys FSE: MOR; NASDAQ: MOR. The transaction is structured as an all-cash tender offer pursuant to which the Companys shareholders will receive 34.00 for each share of Constellation common stock that they hold. 